July 7, 2014 | According to a “Globes” report, Israeli heart valve company Mvalve raised $15 million from Boston Scientific, and international medical device developer, manufacturer and marketer. Mvalve is developing a solution for leaks in the mitral heart valve and in order to complete its product, received a $15 million loan from BSC International Holdings, a member of the Boston Scientific group. Sources reported to “Globes” that BSC obtained an option to acquire Mvalve for up to $200 million. Mvalve was founded in 2012 by Maurice Buchbinder, the inventor of the technology, and CEO Assif Stoffman.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments